289 related articles for article (PubMed ID: 24164241)
1. Targeting sarcoplasmic reticulum calcium ATPase by gene therapy.
Gwathmey JK; Yerevanian A; Hajjar RJ
Hum Gene Ther; 2013 Nov; 24(11):937-47. PubMed ID: 24164241
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for heart failure.
Greenberg B
J Cardiol; 2015 Sep; 66(3):195-200. PubMed ID: 25818479
[TBL] [Abstract][Full Text] [Related]
3. Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b).
Greenberg B; Yaroshinsky A; Zsebo KM; Butler J; Felker GM; Voors AA; Rudy JJ; Wagner K; Hajjar RJ
JACC Heart Fail; 2014 Feb; 2(1):84-92. PubMed ID: 24622121
[TBL] [Abstract][Full Text] [Related]
4. Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.
Greenberg B; Butler J; Felker GM; Ponikowski P; Voors AA; Desai AS; Barnard D; Bouchard A; Jaski B; Lyon AR; Pogoda JM; Rudy JJ; Zsebo KM
Lancet; 2016 Mar; 387(10024):1178-86. PubMed ID: 26803443
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of AAV1/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality.
Zsebo K; Yaroshinsky A; Rudy JJ; Wagner K; Greenberg B; Jessup M; Hajjar RJ
Circ Res; 2014 Jan; 114(1):101-8. PubMed ID: 24065463
[TBL] [Abstract][Full Text] [Related]
6. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure.
del Monte F; Williams E; Lebeche D; Schmidt U; Rosenzweig A; Gwathmey JK; Lewandowski ED; Hajjar RJ
Circulation; 2001 Sep; 104(12):1424-9. PubMed ID: 11560860
[TBL] [Abstract][Full Text] [Related]
7. New insights into SERCA2a gene therapy in heart failure: pay attention to the negative effects of B-type natriuretic peptides.
Zhai Y; Luo Y; Wu P; Li D
J Med Genet; 2018 May; 55(5):287-296. PubMed ID: 29478009
[TBL] [Abstract][Full Text] [Related]
8. Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases.
Lipskaia L; Hadri L; Lopez JJ; Hajjar RJ; Bobe R
Curr Vasc Pharmacol; 2013 Jul; 11(4):465-79. PubMed ID: 23905641
[TBL] [Abstract][Full Text] [Related]
9. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.
Jessup M; Greenberg B; Mancini D; Cappola T; Pauly DF; Jaski B; Yaroshinsky A; Zsebo KM; Dittrich H; Hajjar RJ;
Circulation; 2011 Jul; 124(3):304-13. PubMed ID: 21709064
[TBL] [Abstract][Full Text] [Related]
10. [Overexpression of sarcoplasmic reticulum calcium ATPase induced hemodynamic and proteomic changes in a dog model of heart failure].
Fu ZQ; Li XY; Liu XH; Sun S; Liu T; Mi YF; Zhou SA; Ye WH; Wang QS
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Mar; 36(3):260-5. PubMed ID: 19099986
[TBL] [Abstract][Full Text] [Related]
11. Targeted sarcoplasmic reticulum Ca2+ ATPase 2a gene delivery to restore electrical stability in the failing heart.
Cutler MJ; Wan X; Plummer BN; Liu H; Deschenes I; Laurita KR; Hajjar RJ; Rosenbaum DS
Circulation; 2012 Oct; 126(17):2095-104. PubMed ID: 23019291
[TBL] [Abstract][Full Text] [Related]
12. Sarcoendoplasmic reticulum calcium transport ATPase 2a: a potential gene therapy target in heart failure.
Papolos A; Frishman WH
Cardiol Rev; 2013; 21(3):151-4. PubMed ID: 23568057
[TBL] [Abstract][Full Text] [Related]
13. The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases.
Kawase Y; Hajjar RJ
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):554-65. PubMed ID: 18665137
[TBL] [Abstract][Full Text] [Related]
14. Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.
Lipskaia L; Chemaly ER; Hadri L; Lompre AM; Hajjar RJ
Expert Opin Biol Ther; 2010 Jan; 10(1):29-41. PubMed ID: 20078230
[TBL] [Abstract][Full Text] [Related]
15. Improved cardiac function after sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a heart failure model induced by chronic myocardial ischaemia.
Xin W; Li X; Lu X; Niu K; Cai J
Acta Cardiol; 2011 Feb; 66(1):57-64. PubMed ID: 21446381
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets in heart failure gene therapy: current controversies and translational perspectives.
Kairouz V; Lipskaia L; Hajjar RJ; Chemaly ER
Ann N Y Acad Sci; 2012 Apr; 1254():42-50. PubMed ID: 22548568
[TBL] [Abstract][Full Text] [Related]
17. Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure.
Mattila M; Koskenvuo J; Söderström M; Eerola K; Savontaus M
J Gene Med; 2016 Jul; 18(7):124-33. PubMed ID: 27203155
[TBL] [Abstract][Full Text] [Related]
18. SPEG Controls Calcium Reuptake Into the Sarcoplasmic Reticulum Through Regulating SERCA2a by Its Second Kinase-Domain.
Quan C; Li M; Du Q; Chen Q; Wang H; Campbell D; Fang L; Xue B; MacKintosh C; Gao X; Ouyang K; Wang HY; Chen S
Circ Res; 2019 Mar; 124(5):712-726. PubMed ID: 30566039
[TBL] [Abstract][Full Text] [Related]
19. Targeting phospholamban by gene transfer in human heart failure.
del Monte F; Harding SE; Dec GW; Gwathmey JK; Hajjar RJ
Circulation; 2002 Feb; 105(8):904-7. PubMed ID: 11864915
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic heart failure by overexpressing sarcoplasmic reticulum calcium ATPase through gene therapy: an experiment with rats].
Li XY; Hui HP; Lu XC; Guo YT
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1174-8. PubMed ID: 16796857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
